Cargando…
HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia
BACKGROUND: The emergence of transmitted drug resistance (TDR) compromises the effect of antiretroviral therapy (ART), resulting in treatment failure of human immunodeficiency virus (HIV) disease. Although more than a decade has passed since ART was introduced into Indonesia, information on TDR is l...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336490/ https://www.ncbi.nlm.nih.gov/pubmed/28561075 http://dx.doi.org/10.1186/s12981-015-0046-y |
_version_ | 1782358477449986048 |
---|---|
author | Kotaki, Tomohiro Khairunisa, Siti Qamariyah Witaningrum, Adiana Mutamsari M, Muhammad Qushai Yunifiar Sukartiningrum, Septhia Dwi Diansyah, Muhammad Noor Rahayu, Retno Pudji Nasronudin, ᅟ Kameoka, Masanori |
author_facet | Kotaki, Tomohiro Khairunisa, Siti Qamariyah Witaningrum, Adiana Mutamsari M, Muhammad Qushai Yunifiar Sukartiningrum, Septhia Dwi Diansyah, Muhammad Noor Rahayu, Retno Pudji Nasronudin, ᅟ Kameoka, Masanori |
author_sort | Kotaki, Tomohiro |
collection | PubMed |
description | BACKGROUND: The emergence of transmitted drug resistance (TDR) compromises the effect of antiretroviral therapy (ART), resulting in treatment failure of human immunodeficiency virus (HIV) disease. Although more than a decade has passed since ART was introduced into Indonesia, information on TDR is limited. Here, a genotypic study of TDR among ART-naïve individuals was conducted in Surabaya, Indonesia. METHOD: HIV-1 seropositive participants were recruited from the communities of commercial sex workers and intravenous drug users as well as from the university teaching hospital in Surabaya. Protease (PR) and reverse transcriptase (RT) genes were sequenced in order to conduct HIV-1 subtyping and phylogenetic analysis and to detect TDR. TDR was defined as the presence of at least one surveillance drug resistance mutation on the WHO list or major drug resistance mutations in the International AIDS Society-USA panel. RESULT: Fifty two and 47 of the PR and RT genes, respectively, were successfully sequenced in the 58 samples. HIV-1 subtyping revealed that 86.3% (50/58) of the sequenced samples were classified as CRF01_AE, 8.6% as subtype B, 3.4% as B/CRF01_AE, and 1.7% as A/G/CRF01_AE. TDR of PR inhibitors was not detected in this study. In contrast, TDR of RT inhibitors was detected in 4.3% (2/47) of samples. In addition, minor drug resistance mutations were detected in 98.1% (51/52) and 12.8% (6/47) of PR and RT genes, respectively. CONCLUSION: This study clarified the predominance of the CRF01_AE strain in Surabaya, Indonesia. The prevalence of TDR was below 5%, indicating that the currently available first-line regimen is still effective in Surabaya. However, the prevalence might be underestimated since we detected only major population of HIV-1 in individuals. Therefore, continuous surveillance is required in order to detect the emergence of TDR in the early phase. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12981-015-0046-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4336490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43364902015-02-22 HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia Kotaki, Tomohiro Khairunisa, Siti Qamariyah Witaningrum, Adiana Mutamsari M, Muhammad Qushai Yunifiar Sukartiningrum, Septhia Dwi Diansyah, Muhammad Noor Rahayu, Retno Pudji Nasronudin, ᅟ Kameoka, Masanori AIDS Res Ther Research BACKGROUND: The emergence of transmitted drug resistance (TDR) compromises the effect of antiretroviral therapy (ART), resulting in treatment failure of human immunodeficiency virus (HIV) disease. Although more than a decade has passed since ART was introduced into Indonesia, information on TDR is limited. Here, a genotypic study of TDR among ART-naïve individuals was conducted in Surabaya, Indonesia. METHOD: HIV-1 seropositive participants were recruited from the communities of commercial sex workers and intravenous drug users as well as from the university teaching hospital in Surabaya. Protease (PR) and reverse transcriptase (RT) genes were sequenced in order to conduct HIV-1 subtyping and phylogenetic analysis and to detect TDR. TDR was defined as the presence of at least one surveillance drug resistance mutation on the WHO list or major drug resistance mutations in the International AIDS Society-USA panel. RESULT: Fifty two and 47 of the PR and RT genes, respectively, were successfully sequenced in the 58 samples. HIV-1 subtyping revealed that 86.3% (50/58) of the sequenced samples were classified as CRF01_AE, 8.6% as subtype B, 3.4% as B/CRF01_AE, and 1.7% as A/G/CRF01_AE. TDR of PR inhibitors was not detected in this study. In contrast, TDR of RT inhibitors was detected in 4.3% (2/47) of samples. In addition, minor drug resistance mutations were detected in 98.1% (51/52) and 12.8% (6/47) of PR and RT genes, respectively. CONCLUSION: This study clarified the predominance of the CRF01_AE strain in Surabaya, Indonesia. The prevalence of TDR was below 5%, indicating that the currently available first-line regimen is still effective in Surabaya. However, the prevalence might be underestimated since we detected only major population of HIV-1 in individuals. Therefore, continuous surveillance is required in order to detect the emergence of TDR in the early phase. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12981-015-0046-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-22 /pmc/articles/PMC4336490/ /pubmed/28561075 http://dx.doi.org/10.1186/s12981-015-0046-y Text en © Kotaki et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kotaki, Tomohiro Khairunisa, Siti Qamariyah Witaningrum, Adiana Mutamsari M, Muhammad Qushai Yunifiar Sukartiningrum, Septhia Dwi Diansyah, Muhammad Noor Rahayu, Retno Pudji Nasronudin, ᅟ Kameoka, Masanori HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia |
title | HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia |
title_full | HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia |
title_fullStr | HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia |
title_full_unstemmed | HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia |
title_short | HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia |
title_sort | hiv-1 transmitted drug resistance mutations among antiretroviral therapy-naïve individuals in surabaya, indonesia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336490/ https://www.ncbi.nlm.nih.gov/pubmed/28561075 http://dx.doi.org/10.1186/s12981-015-0046-y |
work_keys_str_mv | AT kotakitomohiro hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT khairunisasitiqamariyah hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT witaningrumadianamutamsari hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT mmuhammadqushaiyunifiar hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT sukartiningrumsepthiadwi hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT diansyahmuhammadnoor hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT rahayuretnopudji hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT nasronudinᅟ hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia AT kameokamasanori hiv1transmitteddrugresistancemutationsamongantiretroviraltherapynaiveindividualsinsurabayaindonesia |